Most studied Y-90 HCC therapy
TheraSphere Y-90 Glass Microspheres are a proven, evidence-based HCC therapy that hits tumors hard. Now you have the power to reliably shrink and destroy tumors and enhance outcomes.
- TheraSphere’s 20+ year legacy is backed by significant investments in clinical evidence with more than 100,000 patient treatments globally.
- With clinical studies enrolling more than 2,000 patients worldwide, TheraSphere has demonstrated success in improving tumor response and extending patient survival.